{
    "2018-10-03": [
        [
            {
                "time": "2018-10-03",
                "original_text": "['Merck', 'CEO', 'sees', 'a', 'disintermediation', 'in', 'pharma', 'like', 'the', 'cable', 'industry']",
                "features": {
                    "keywords": [
                        "Merck",
                        "CEO",
                        "disintermediation",
                        "pharma",
                        "cable industry"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Platinum', 'Equity', 'completes', '$2B', 'purchase', 'of', 'J&J’s', 'LifeScan']",
                "features": {
                    "keywords": [
                        "Platinum Equity",
                        "purchase",
                        "J&J",
                        "LifeScan"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Mergers', 'and', 'Acquisitions', 'in', 'the', 'Pharmaceuticals', 'Sector', 'in', 'Q3', '2018']",
                "features": {
                    "keywords": [
                        "Mergers",
                        "Acquisitions",
                        "Pharmaceuticals",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Here's', 'Why', 'J&J', '(JNJ)', 'is', 'a', 'Good', 'Bet', 'in', 'a', 'Troubled', 'Market']",
                "features": {
                    "keywords": [
                        "J&J",
                        "Good Bet",
                        "Troubled Market"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Novartis,', 'Boston', 'Pharma', 'Ink', 'Deal', 'for', '3', 'Anti-Infective', 'Drugs']",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Boston Pharma",
                        "Deal",
                        "Anti-Infective Drugs"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Merck', '&', 'Other', 'Pharma', 'Players', 'Await', 'FDA', 'Decisions', 'in', 'October']",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pharma Players",
                        "FDA Decisions"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['MARKETS:', 'Dow', 'hits', 'another', 'record', 'with', 'Intel,', 'Apple,', 'Caterpillar', 'leading—even', 'small', 'caps', 'are', 'on', 'board']",
                "features": {
                    "keywords": [
                        "Dow",
                        "record",
                        "Intel",
                        "Apple",
                        "Caterpillar",
                        "small caps"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['A', 'Look', 'at', 'Elanco,', 'Eli', 'Lilly’s', 'Animal', 'Health', 'Business']",
                "features": {
                    "keywords": [
                        "Elanco",
                        "Eli Lilly",
                        "Animal Health Business"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Health', 'Care', 'Sector', 'Update', 'for', '10/03/2018:', 'JNJ,', 'PFE,', 'AMGN,', 'MRK,', 'ABT,', 'ELGX,', 'NVCN,', 'KALA']",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "JNJ",
                        "PFE",
                        "AMGN",
                        "MRK",
                        "ABT",
                        "ELGX",
                        "NVCN",
                        "KALA"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Bristol-Myers', 'Squibb', 'Company', '(BMY)', 'Ex-Dividend', 'Date', 'Scheduled', 'for', 'October', '04,', '2018']",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Ex-Dividend Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Dow', 'Jones', 'Futures', 'Rise', 'On', 'Italy:', 'Upwork', 'IPO', 'Set', 'To', 'Debut;', 'News', 'On', 'Nike,', 'Microsoft,', 'J&J']",
                "features": {
                    "keywords": [
                        "Dow Jones Futures",
                        "Rise",
                        "Italy",
                        "Upwork IPO",
                        "Nike",
                        "Microsoft",
                        "J&J"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "['Will', 'This', 'IRS', 'Spinoff', 'Rule', 'Help', 'Pharma', 'and', 'Big', 'Tech?']",
                "features": {
                    "keywords": [
                        "IRS Spinoff Rule",
                        "Pharma",
                        "Big Tech"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}